Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolio
Close

Bellevue Healthcare Strategy I (0P0000X5CW)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3,677.270 +19.510    +0.53%
16/05 - Closed. Currency in CHF ( Disclaimer )
  • Morningstar Rating:
  • Total Assets: 222.8M
Type:  Fund
Market:  Switzerland
ISIN:  CH0137596661 
Asset Class:  Equity
BB Adamant Global Healthcare Index Fonds I Klasse 3,677.270 +19.510 +0.53%

0P0000X5CW Overview

 
On this page you'll find an in-depth profile of Bellevue Healthcare Strategy I. Learn about the key management, total assets, investment strategy and contact information of 0P0000X5CW among other information.
Category

Sector Equity Healthcare

Total Assets

222.8M

Expenses

0.81%

Inception Date

Oct 19, 2011

Contact Information

Address Kusnacht
Küsnacht, 8700
Switzerland
Phone +41442676700
Fax +41442676701

Top Executives

Name Title Since Until
Terence McManus - 2023 Now
Biography Terence McManus is a Portfolio Manager at J. Safra Sarasin Asset Management (JSS AM). He is a Portfolio Manager of the ‘JSS Sustainable Equities – Future Health’ strategy. Terence McManus joined JSS AM in February 2020. Prior to this, Terence was the global healthcare equity analyst at Julius Baer in Zurich for four years, where he also advised and administered a global equity strategy. Terence started covering pharmaceutical stocks as an equity analyst on the sell-side in 2010 at Jefferies, and then later at Credit Suisse in London. Terence started his career in 2002 at a Biotech start-up where he was a founding scientist, before moving into healthcare industry consulting. He holds a PhD in Neurophysiology and BSc in Pharmacology.
Zahide Donat - 2022 Now
Biography Since2015 Junior Portfolio Manager; 2014-2015 Credit Suisse AG, Banking Operations Specialist in Fixed Income; 2010-2013 Migros Bank AG, Relationship Manager; Bachelor of Science ZFH in Business Administration (Focus Banking and Finance)
Samuel Stursberg - 2022 2023
Biography Since 2015 Head Research Health Care Funds & Mandates; 2007-2014 Head Research at Adamant Biomedical Investment AG; 2005-2007 Stock analysis medtech and biotech at Bank Sarasin; 2001-2005 Sustainable Asset Management, stock analysis in healthcare; M.Sc University of Basel, MBA HSG, CFA
Oliver Kubli - 2011 2021
John Manieri - 2011 2021
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000X5CW Comments

Write your thoughts about Bellevue Healthcare Strategy I
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email